The Data Library is in beta. Stay tuned for more features and packages over the coming months!
Target Identification Data Package
Subscription Required
Adverse Effects Module
Each structured adverse effect represents a known adverse effect of a given drug, when used in a specific situation. Some adverse effects are specific to a certain route of administration, or patients of a certain age group.
Covers 156,902 linked with 2,132 drugs and connecting to more than 11,900 unique symptoms and effects.
Includes effects, administration and patient
attributes, prevalence, and associated ICD-10 and
MedDRA identifier
The Adverse Effects Module has 6 tables. Open the schema diagram to see how they connect.
adverse_effect_id | relationship | value |
---|---|---|
00001864-8ab9-459c-a972-80b6de645515 | age_group | adult |
00001864-8ab9-459c-a972-80b6de645515 | dose_form | Injection, suspension |
00001864-8ab9-459c-a972-80b6de645515 | evidence_type | clinical_trial |
00001864-8ab9-459c-a972-80b6de645515 | route | Intravenous |
00001864-8ab9-459c-a972-80b6de645515 | trial_name | CARTITUDE |
adverse_effect_id | category_id |
---|---|
000ef077-8100-4780-a0f9-490449837f23 | 123 |
00237de4-2c17-4c15-9ab2-bef6129fdd9c | 2788 |
0066f9e7-ef0e-4522-91f5-7ff4f71301ae | 401 |
00704f1e-9639-4e29-8038-6a0cb8b91fe2 | 2235 |
00aadc62-58be-4da0-b3d3-815755b7254b | 3419 |
adverse_effect_id | condition_id | relationship |
---|---|---|
00001864-8ab9-459c-a972-80b6de645515 | 111386 | patient_characteristic |
00001864-8ab9-459c-a972-80b6de645515 | 145907 | effect |
0000a9e9-a7aa-47f5-86de-ee6f3502441f | 40804 | effect |
0000e294-507b-49d3-8453-0131edcb8917 | 135 | patient_characteristic |
0000e294-507b-49d3-8453-0131edcb8917 | 3824 | effect |
adverse_effect_id | drug_id |
---|---|
000bd176-e243-477b-aabe-97f054d3a522 | 864 |
000dbdee-5929-4e17-a73e-de2e1ac092af | 987 |
001b0c92-31be-457d-8f82-4a30110697de | 9416 |
001b9172-9755-448c-8f9c-2bca716bc18e | 586 |
001e8010-d4fc-4b13-b804-5c2729019b7f | 9305 |
adverse_effect_id | id | kind | name | percent | percent_descriptor | p_value |
---|---|---|---|---|---|---|
00001864-8ab9-459c-a972-80b6de645515 | 2f6f40cb-9b42-4481-8fee-b939e3e399ef | experimental | 2 | |||
0000a9e9-a7aa-47f5-86de-ee6f3502441f | add4d89d-4c3c-4e1d-ab5c-691c6f0b4083 | experimental | <3% | |||
0000e294-507b-49d3-8453-0131edcb8917 | dc6b4c07-cb02-4f7d-adfc-c230daa58860 | experimental | <2 | |||
00021d6e-d3b9-4924-8539-db45c84e0b7f | 22d7eabd-b168-46d9-9694-616922e9ba53 | experimental | 9 | |||
00023ffe-6777-4cc8-8d8a-83b2a40b3e1e | d0c1276e-805c-4599-bc7a-9253fbc534c1 | experimental | <1% |
id | drug_id | region | admin | usage | event | sex_group | min_age_amount | min_age_unit | max_age_amount | max_age_unit |
---|---|---|---|---|---|---|---|---|---|---|
00001864-8ab9-459c-a972-80b6de645515 | 22980 | US | ||||||||
0000a9e9-a7aa-47f5-86de-ee6f3502441f | 9294 | US | 53 | year | ||||||
0000e294-507b-49d3-8453-0131edcb8917 | 582 | US | all | 11 | year | 90 | year | |||
00021d6e-d3b9-4924-8539-db45c84e0b7f | 12975 | US | once weekly in 21-day treatment cycles | |||||||
00023ffe-6777-4cc8-8d8a-83b2a40b3e1e | 401 | US |
Showing 6 of 6 tables